Cytochrome P450 (CYP) 2E1 is a major CYP isoform expressed in the human liver.
Cytochrome P450 (CYP) 2E1 is a major CYP isoform expressed in the human liver. 1) Human CYP2E1 is responsible for activation of carcinogenic nitrosamines such as dimethyland diethylnitrosamine. [2] [3] [4] Human CYP2E1 is characteristic in its substrate recognition as follows: CYP2E1 metabolizes hydrophilic substrates such as EtOH and acetone, 5) and also it metabolizes small molecules such as benzene and chloroform. 6, 7) Because human CYP2E1 is reported to be inducible by alcohol intake, 8) fasting, 9) and diabetes, 10) it is an important CYP isoform for the investigation of drug-drug interactions.
Various specific inhibitors are known for some CYP isoforms: furafylline and fluvoxamine for 1A2, 11, 12) sulfaphenazole for 2C9, 13) omeprazole and ticlopidine for 2C19, 14, 15) quinidine for 2D6, 16) and ketoconazole and troleandomycin for 3A4. 17, 18) Although diethyldithiocarbamate (DDTC) is a specific inhibitor of CYP2E1, 7, 19) there have been few reports on other types of potent CYP2E1 inhibitors.
Aniline hydroxylation is catalyzed by CYP2E1, 5) but aniline is a very weak inhibitor of CYP2E1. It is well-known that enzyme-substrate interactions could be affected by substitution by a functional group(s) such as halogen atom because of its electronegativity and lipophilicity. 20, 21) Therefore, in order to clarify halogen-substitution effects on the CYP2E1 inhibition of anilines and to search for potent inhibitors of CYP2E1, halogenated anilines, phenols and thiophenols were subjected to analysis of their structure-inhibitory activity relationships using recombinant human CYP2E1.
MATERIALS AND METHODS

Materials
The microsome preparations from bacurovirus-infected insect cells expressing CYP2E1 and CYP1A2, which were coexpressed with NADPH-CYP oxidoreductase, were purchased from Gentest Co. (Woburn, MA, U.S.A.), NADP, glucose-6-phosphate (G6P), and G6P dehydrogenase from Oriental Yeast Co. (Tokyo), 2,3-dichlorothiophenol from Wako Pure Chemicals (Osaka), and all the other chemicals from Aldrich.
Inhibition of CYP2E1 Activity as Determined by Quinoline 3-Hydroxylation The incubation mixture (50 ml) contained 0.1 M potassium phosphate buffer (pH 7.4), 1.3 mM NADP, 3.3 mM G6P, 3.3 mM MgCl 2 , 0.08 units of G6P dehydrogenase, 0.5 mM quinoline, inhibitor (0 to 500 mM), and 1.0 pmol CYP (1.7 mg protein). After incubation at 37°C for 60 min, the resulting metabolites were extracted with 2.5 volumes of ethyl acetate, and the organic solvent layer was evaporated. The residue was dissolved in 200 ml of 0.5 M Tris base-10% DMSO solution and added to the wells of a 96-well plate. The production of fluorescent 3-hydroxyquinoline (460 nm emission and 355 nm excitation) was recorded with an ARVO1420 Multilabel Counter and the relative fluorescence was compared to a calibration curve. Inhibition effects were calculated as IC 50 . At least three independent experiments were performed.
RESULTS AND DISCUSSION
Reigh et al., reported that CYP2E1 is the principal CYP isozyme involved in the formation of 3-hydroxyquinoline in human liver microsomes. 22) In their report, 3-hydroxyquinoline was detected with an HPLC-UV detector (290 nm) by the same method as described in our previous paper. 23) This detection method of 3-hydroxyquinoline was not sensitive enough to detect submicro-molar levels. In the present study, we detected 3-hydroxyquinoline formation by fluorescence monitoring (Exϭ355 nm and Emϭ460 nm), and the detection limit of 3-hydroxyquinoline was about 80 nM (S/Nϭ1.5). Figure 1 shows the time-dependent increase of quinoline 3-hydroxylation by recombinant human CYP2E1 and the metabolism proceeding linearly up to 120 min. Quinoline 3-hydroxylation was potently inhibited by diethyldithiocarbamate (DDTC), a specific inhibitor of CYP2E1, and its IC 50 was 8.9 mM. The result suggests that the fluorescence method for determination of quinoline 3-hydroxylation may be useful for monitoring CYP2E1 activity. Table 1 shows the effect of halogen-substitution in 32 aniline derivatives on the CYP2E1 inhibition. Aniline showed very weak or no inhibition (IC 50 Ͼ500 mM) at all of CYP2E1 activity by the present assay. Among all the monohalogenated anilines, 4-chloro and 4-bromo derivatives showed higher inhibitory activities than those of aniline and the other monohalogenated anilines, and the halogen-substitution effect on the inhibition activity decreased in the following order, 4-BrϷ4-ClϾ3-ClϷ3-BrϾ Ͼ4-FϾ3-F, 2-F, 2-Cl, 2-Br, and aniline. The result indicates that the CYP2E1 inhibition of aniline was more enhanced by chlorine-and bromine-substitution than by fluorine-substitution, and it was more enhanced by para-and metha-halogen-substitution than by ortho-halogen-substitution. Almost the same tendency was obtained in dihalogen-substituted anilines. Dichloro-and dibromoanilines showed higher inhibitory effects than difluoroanilines with all the substituted positions, and 3,4-and 3,5-dichloroaniline showed higher inhibitory effects than the other dichloroanilines, in which the ortho-position was substituted by chorine atom(s). Moreover, the inhibition activities of 2,3,4-trichloro-and 2,4,5-trichloroaniline were higher than those of 2,3,4-trifluoro-and 2,4,5-trifluoroaniline, respectively. Among all the halogenated anilines, 3,4-and 3,5-dichloro derivatives showed highest inhibitory activities and their IC 50 values were 8.0 mM and 9.2 mM, respectively. These inhibitory activities of 3,4-and 3,5-dichloroanilines were the same as or higher than that of DDTC. These results suggest that the 3,4-and 3,5-dichlorophenyl structures may be essential for CYP2E1 inhibition.
To investigate the function of the amino group for the inhibitory effect of the dichlorophenyl structure, dichlorophenols and dichlorothiophenols were subjected to analysis of their CYP2E1 inhibition. As shown in Table 2 , the positionspecific effects of dichlorine-substitution in phenols and thiophenols were very similar to those observed in anilines. Dichlorothiophenols showed similar or more potent inhibitory activities than dichloroanilines when compared with respect to each substituted position. On the other hand, dichlorophenols showed less inhibitory activities than dichloroanilines and dichlorothiophenols with all the substituted positions. These results suggest that basic functional groups such as the amino and thiol may be important for CYP2E1 inhibition in the dichlorophenyl structure. Among the dichlorophenols and dichlorothiophenols, 3,4-and 3,5-dichlorothiophenols showed very potent inhibition and their IC 50 values were 5.3 and 5.2 mM, respectively.
To investigate the CYP selectivity of the 3,4-and 3,5-dichloro derivatives of aniline and thiophenol, these compounds were subjected to analysis of their inhibitory effect on recombinant human CYP1A2, which was reported as a high affinity isoform involved in the formation of 3-hydroxyquinoline. 22) Although DDTC and 3,4-and 3,5-dichloroanilines showed no inhibition of CYP1A2 (IC 50 Ͼ200 mM), 3,4-and 3,5-dichlorothiophenols showed moderate inhibition of CYP1A2 (IC 50 ϭ73Ϯ9 and 168Ϯ21 mM, respectively). These results suggest that 3,4-and 3,5-dichloroanilines might be mechanism-based inhibitors of CYP2E1 like DDTC.
In conclusion, the 3,4-and 3,5-dichloro derivatives, especially those of aniline, may be useful as potent inhibitors of human CYP2E1. Further investigations such as selectivity toward other CYP isozymes and inhibition mechanism(s) of these dichlorophenyl derivatives are now underway.
